Description:
PT-2385 is a small molecule inhibitor with oral activity that inhibits hypoxia inducible factor (HIF)-2alpha heterodimerization and its subsequent binding to DNA by binding to HIF-2alpha.
- Molecular Weight:383.34
- Boiling Point:524.7±50.0 °C | Condition: Press: 760 Torr
Molecular Formula:
C17H12F3NO4S
Canonical SMILES:
CS(=O)(=O)C1=C2C(C(CC2=C(C=C1)OC3=CC(=CC(=C3)C#N)F)(F)F)O
InChI:
1S/C17H12F3NO4S/c1-26(23,24)14-3-2-13(12-7-17(19,20)16(22)15(12)14)25-11-5-9(8-21)4-10(18)6-11/h2-6,16,22H,7H2,1H3/t16-/m0/s1
InChIKey:
ONBSHRSJOPSEGS-INIZCTEOSA-N
Appearance:
Solid powder
Storage: Store in a cool and dry place and at 0 - 4℃ for short term (days to weeks) or -68℃ for long term (months to years).
Synonyms:
3-[[(1S)-2,2-difluoro-1-hydroxy-7-methylsulfonyl-1,3-dihydroinden-4-yl]oxy]-5-fluorobenzonitrilePT-2385; PT2385; PT 2385SCHEMBL165558103-{[(1s)-2,2-Difluoro-1-Hydroxy-7-(Methylsulfonyl)-2,3-Dihydro-1h-Inden-4-Yl]oxy}-5-Fluorobenzonitrile79A Weitere Informationen finden Sie
hier